Christopher P. Stewart - 13 May 2022 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Chief Financial Officer
Signature
/s/ Christopher P. Stewart
Issuer symbol
BNGO
Transactions as of
13 May 2022
Net transactions value
+$33,600
Form type
4
Filing time
16 May 2022, 21:31:58 UTC
Previous filing
15 Feb 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNGO Common Stock Options Exercise $33,600 +60,000 +97% $0.5600 121,579 13 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Options Exercise $0 -60,000 -34% $0.000000 117,500 13 May 2022 Common Stock 60,000 $0.5600 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,139 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2021 and 2,940 shares acquired under the ESPP on December 10, 2021.
F2 The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person.